| Literature DB >> 2149281 |
T Tominaga1, O Abe, M Izuo, Y Nomura.
Abstract
A Phase I study of the new antiestrogenic drug toremifene was carried out in 27 Japanese women, using oral doses of 10-480 mg per day for one or five days. Serum concentrations reached a dose-dependent maximum 2-6 hours after each oral administration. Side effects were generally mild.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2149281 DOI： 10.1007/bf01807141
Source DB: PubMed Journal: Breast Cancer Res Treat ISSN： 0167-6806 Impact factor: 4.872